We are live on ! Find out more
TLSA icon

Tiziana Life Sciences
TLSA

25 hedge funds and large institutions have $4.15M invested in Tiziana Life Sciences in 2022 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 10 increasing their positions, 3 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

233% more repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 3

100% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 1

4% more funds holding

Funds holding: 24 → 25 (+1)

4% more capital invested

Capital invested by funds: $3.97M → $4.15M (+$177K)

0% less ownership

Funds ownership: 5.21% → 5.21% (-0%)

Holders
25
Holders Change
+1
Holders Change %
+4.17%
% of All Funds
0.43%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
10
Reduced
3
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
CF
Cantor Fitzgerald
New York
+$34.6K
2
Morgan Stanley
Morgan Stanley
New York
+$23.4K
3
Citigroup
Citigroup
New York
+$19.4K
4
UBS Group
UBS Group
Switzerland
+$12.3K
5
Jane Street
Jane Street
New York
+$7.63K

Top Sellers

Rank Fund Capital Flow
1
State Street
State Street
Massachusetts
-$78.6K
2
Citadel Advisors
Citadel Advisors
Florida
-$37K
3
CS
Credit Suisse
Switzerland
-$1.88K
4
HighTower Advisors
HighTower Advisors
Illinois
-$1.43K

TLSA Hedge Fund Activity: Q3 2022 in Review

25 of the 5,829 institutional investors tracked by Wall St. Rank reported a position in Tiziana Life Sciences (TLSA) for Q3 2022, worth a combined $4.15M — up 4.5% from $3.97M a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new TLSA positions and 1 closed out — a net gain of 1 holder — while 10 added to existing stakes and 3 trimmed.

The largest buyer was Cantor Fitzgerald, opening a new position worth an estimated $34.6K. The largest seller was State Street, cutting an estimated $78.6K.

  • 25 institutional investors held Tiziana Life Sciences (TLSA) as of Q3 2022, up from 24 in Q2 2022.
  • Funds reported $4.15M of Tiziana Life Sciences stock for Q3 2022, up 4.5% quarter-over-quarter.
  • 2 funds opened new Tiziana Life Sciences positions in Q3 2022 and 1 closed out, a net change of +1 holder.
  • The largest Tiziana Life Sciences buyer in Q3 2022 was Cantor Fitzgerald, an estimated $34.6K added.
  • The largest Tiziana Life Sciences seller in Q3 2022 was State Street, an estimated $78.6K sold.

Based on aggregated 13F filings for Q3 2022.